Saniona AB (publ) (STO:SANION)
10.24
+1.22 (13.46%)
Oct 13, 2026, 11:39 AM CET
Saniona AB Market Cap
Saniona AB has a market cap or net worth of 1.41 billion as of October 12, 2026. It is the 23,901st most valuable company in the world and the 297th biggest in Sweden. Its market cap has decreased by 15.51% in one year.
Market Cap
1.41B
Enterprise Value
927.11M
Revenue
424.56M
Global Rank
Country Rank
#297 Sweden
PE Ratio
6.91
ChartMarket Cap Chart
Since April 22, 2014, Saniona AB's market cap has increased from 71.49M to 1.41B, an increase of 1,877.01%. That is a compound annual growth rate of 27.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.41B | -51.70% |
| Dec 30, 2025 | 2.93B | 223.43% |
| Dec 30, 2024 | 904.76M | 251.84% |
| Dec 29, 2023 | 257.15M | 34.48% |
| Dec 30, 2022 | 191.21M | -65.37% |
| Dec 30, 2021 | 552.11M | -57.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.53B |
| BioInvent International AB | 1.53B |
| Flerie AB | 1.36B |
| Genovis AB (publ.) | 1.35B |
| Oncopeptides AB | 1.01B |
| Infant Bacterial Therapeutics AB | 999.58M |
| SynAct Pharma AB | 958.69M |
| Medivir AB | 927.32M |